LncRNA OIP5‐AS1 Modulates the Biological Behaviour of Lung Cancer Cells by Regulating the hsa‐miR‐29b‐3p/ZIC5 Axis
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Long Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, MicroRNAs, Lung Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Existing knowledge regarding the involvement of lncRNA OIP5 ‐ AS1 in lung adenocarcinoma ( LUAD ) development is still incomplete and requires further investigation. Our research aimed to reveal the function of OIP5 ‐ AS1 in LUAD . We evaluated the level of OIP5 ‐ AS1 and its association with clinicopathological factors in LUAD . The research examined the potential implications of targeting OIP5 ‐ AS1 in mitigating the invasive properties of lung cancer cells. A nude mouse xenograft model was utilised to examine tumour growth. We used bioinformatics data and a dual‐luciferase reporter assay to study the interactions between OIP5 ‐ AS1 and hsa‐ miR ‐29b‐3p. OIP5 ‐ AS1 was significantly overexpressed in LUAD , with a higher level correlating with adverse clinicopathological features. Knockdown of OIP5 ‐ AS1 resulted in notable decreases in LUAD cell growth, movement, and aggressive behaviour, accompanied by a decrease in tumour size in vivo. Furthermore, OIP5 ‐ AS1 was confirmed to act as a molecular sponge for hsa‐ miR ‐29b‐3p. The elevated expression of hsa‐ miR ‐29b‐3p intensified the inhibitory outcomes of OIP5 ‐ AS1 knockdown on LUAD cell properties. ZIC5 was experimentally determined to be a direct molecular target of hs‐ miR ‐29b‐3p, emphasising its integral position in the regulatory interaction. This study reveals a new regulatory route involving OIP5 ‐ AS1 , hsa‐ miR ‐29b‐3p and ZIC5 in LUAD pathogenesis. Given its oncogenic traits, OIP5 ‐ AS1 presents a promising predictive biomarker and therapeutic target for optimising lung cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
ORCID-Profile: Long Liang, Yongchang Sun
Zitieren
APA
Liang, L., Luo, Y., Li, D., & Sun, Y. (2025). LncRNA OIP5‐AS1 Modulates the Biological Behaviour of Lung Cancer Cells by Regulating the hsa‐miR‐29b‐3p/ZIC5 Axis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70596
Vancouver
Liang L, Luo Y, Li D, Sun Y. LncRNA OIP5‐AS1 Modulates the Biological Behaviour of Lung Cancer Cells by Regulating the hsa‐miR‐29b‐3p/ZIC5 Axis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70596
BibTeX
@article{Liang2025,
author = {Liang, Long and Luo, Ying and Li, Danyang and Sun, Yongchang},
title = {LncRNA OIP5‐AS1 Modulates the Biological Behaviour of Lung Cancer Cells by Regulating the hsa‐miR‐29b‐3p/ZIC5 Axis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70596}
}
EUVIMED